High-dose potassium resuscitation in a peritoneal dialysis patient with severe hypokalemia and torsades de pointesIntroduction: Acute aortic dissection (AAD) is one of the most challenging cardiovascular emergencies presenting to the Emergency Department (ED). Prompt diagnosis and treatment is the key to...
Treatment of hyperkalemia must be individualized based on the underlying cause of the hyperkalemia, the severity of symptoms or appearance of ECG changes, and the overall health status of the patient. Mild hyperkalemia is usually treated without hospitalization especially if the patient is otherwise hea...
Patient Counseling InformationHighlights of Prescribing Information These highlights do not include all the information needed to use POTASSIUM CITRATE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for POTASSIUM CITRATE EXTENDED-RELEASE TABLETS. POTASSIUM CITRATE Extended-relea...
for the mother.Oligohydramnios may not appear until after irreversible injury to the fetus.Closely observe neonates exposed to losartan in utero for signs of hypotension, oliguria, and hyperkalemia.If oliguria or hypotension occurs, support BP and renal perfusion.Exchange transfusions or dialysis may...
No dialysis treatments were missed, and medication use remained unchanged during the study period. Timing of blood collection varied between patients, but there was a relative constant collection time within patients (±30 minutes across weeks). Table 1. Baseline patient characteristics VariableMean ±...
If you have too much potassium or hyperkalemia it may produce symptoms like muscle weakness, irregular heartbeat, or nausea. Hormone problems or taking certain drugs may result in elevated potassium levels. Doctors treat hyperkalemia with certain medications or with dialysis, which removes waste from...
Section > Chapter Beigelman, P.M. American Journal of Medicine 54(4): 419-420 1973 ISSN/ISBN:0002-9343 4633105 10.1016/0002-9343(73)90037-5 000165540 Article/Abstract emailed within 0-6 h Buy Now for$19.90 Payments are secure & encrypted ...
The concentration of potassium in our cells is some 37 times higher than in the extracellular compartment. Maintenance of this transcellular concentration gradient is central for normal cell function in general and for nerve conduction and muscle contrac
of low-dose MRA provides cardioprotective effects in bothhemodialysisandperitoneal dialysispatients without significantly increasing the risk of hyperkalemia. MRA may improve mortality in ESKD dialysis patients, but larger studies are needed to establish safe protocols for their use in dialysis patients. ...
Immune thrombocytopenia has been reported3 in a patient short- ly after starting losartan. 1. Horn S, et al. Losartan and renal transplantation. Lancet 1998; 351: 111. 2. Schwarzbeck A, et al. Anaemia in dialysis patients as a side- effect of sartanes. Lancet 1998; 352: 286. 3. Ada...